Synthesis and Antibacterial Activity of Novel Ethyl 2-Alkoxyimino-2-benzimidazol-2-yl Acetates Bearing a Morpholine Group

Peizhi Zhang,Fuxian Wan,Ying Li,Chengkun Li,Lin Jiang
DOI: https://doi.org/10.1007/s11164-013-1437-0
IF: 3.134
2013-01-01
Research on Chemical Intermediates
Abstract:In the search for new benzimidazole derivatives with high antibacterial activity and for which bacterial resistance is low, novel ethyl 2-(alkoxyimino)-2-[1-(4-morpholinocarbonylmethyl)-1H-benzimidazol-2-yl]acetates have been synthesized by multi-step reactions and characterized by 1H NMR, IR, and ESI–MS analysis. The compounds were evaluated for in-vitro antibacterial activity against Escherichia coli and Staphylococcus aureus. The results revealed that four of the compounds had excellent bioactivity against S. aureus, with IC50 values of 12.72–26.58 μg/mL, even better than that of the control agent (levofloxacin hydrochloride).
What problem does this paper attempt to address?